Source-aware
We identify the kind of source behind a claim and encourage readers to notice the difference between a research paper, an official notice, an anecdote, and a marketing statement.
Slow Ledger 2
An independent resource for careful ibogaine information. Cobalt Thistle exists to make difficult material easier to locate, assess, and hold with appropriate caution.
We built the starting point for careful context for people who need a calm alternative to promotional language, fragmented claims, and false certainty. The aim is not to direct a decision; it is to make the limits of available information visible.
Why this exists
Slow Ledger 2 is organized around a simple premise: high-risk investigational treatment information deserves plain language, visible uncertainty, and room for people to pause. We cover ibogaine once as the subject of this resource, while keeping the focus on how evidence, risk, legality, and ethical questions are communicated.
For readers comparing how information is framed across the web, ibogaine news context can show why source date and framing matter. Our own role is narrower: identify what a source says, distinguish it from what it cannot establish, and avoid turning background material into a recommendation.
Our editorial approach
Our approach begins with primary and official material where possible: study registries, peer-reviewed literature, public agency information, and formal legal or regulatory sources. A registry record, for example, is useful for locating a study but does not by itself settle effectiveness or safety; the ClinicalTrials.gov registry makes that distinction easier to inspect.
We separate established facts from preliminary findings, individual accounts, commercial claims, and unresolved questions. That practice follows the broader expectation that research claims should be assessed in relation to their methods and limits, as described in the National Academies discussion of reproducibility.
We identify the kind of source behind a claim and encourage readers to notice the difference between a research paper, an official notice, an anecdote, and a marketing statement.
Our scope and information pathways are arranged to support orientation rather than to funnel readers toward a provider, product, or treatment choice.
Technical language has a place, but it should not obscure uncertainty. We aim to translate terms without flattening the cautions attached to them.
We do not operate as a clinic, medical provider, or licensed treatment center. We do not provide medical or legal advice, screening, referrals, or operational guidance.
Who this is for
Slow Ledger 2 is for people exploring questions, along with families, advocates, and professionals seeking careful context. Some readers arrive while comparing broad claims about reported ibogaine benefits; others are trying to understand why the language around ibogaine and depression requires particular care. In either case, the resource is meant to support more informed reading, not to interpret an individual situation.
We also recognize that search terms can carry assumptions. Pages discussing ibogaine street names or the plants associated with ibogaine may be useful entry points, but they are not substitutes for credible primary context. When terms have cultural or historical dimensions, we seek language that does not erase those dimensions.
“Careful information does not promise certainty. It makes the uncertainty legible.”
We organize material by question type—research, risk, legal context, ethical considerations, and information quality—so readers can locate context without mistaking organization for endorsement.
We do not rank providers or locations. References to pages such as treatment location listings, Florida treatment searches, or Seattle treatment information are contextual only and do not constitute a referral or approval.
Independent by design
Slow Ledger 2 is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice.